292 related articles for article (PubMed ID: 18510516)
1. Back to the future: a recent history of haemophilia treatment.
Mannucci PM
Haemophilia; 2008 Jul; 14 Suppl 3():10-8. PubMed ID: 18510516
[TBL] [Abstract][Full Text] [Related]
2. [New approaches to haemophilia treatment--recombinant and transgenic concentrates, gene therapy and engineered coagulation factors].
Habart D
Cas Lek Cesk; 2006; 145(2):104-11. PubMed ID: 16521398
[TBL] [Abstract][Full Text] [Related]
3. The challenge arising from the cost of haemophilia care: an audit of haemophilia treatment at Auckland Hospital.
Harper P; Brasser M; Moore L; Teague L; Pitcher L; Ockelford P
N Z Med J; 2003 Aug; 116(1180):U561. PubMed ID: 14581983
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy for hemophilia A.
Gan SU; Calne RY
Discov Med; 2006 Oct; 6(35):198-202. PubMed ID: 17234142
[TBL] [Abstract][Full Text] [Related]
5. [Hemophilia--present and past].
Terada H
Nihon Rinsho; 2008 Mar; 66(3):591-9. PubMed ID: 18330030
[TBL] [Abstract][Full Text] [Related]
6. [Current status and future prospects of hemophilia treatment].
Lopaciuk S
Acta Haematol Pol; 1995; 26(2 Suppl 1):44-55. PubMed ID: 7653234
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy for haemophilia...yes, but...with non-viral vectors?
Liras A; Olmedillas S
Haemophilia; 2009 May; 15(3):811-6. PubMed ID: 19432929
[TBL] [Abstract][Full Text] [Related]
8. Factors impeding efficient expression of factor VIII complementary DNA minigenes.
Hoeben RC; Fallaux FJ; Schagen FH; van der Eb MM; van Ormondt H; van der Eb A
Blood Coagul Fibrinolysis; 1997 Dec; 8 Suppl 2():S15-21. PubMed ID: 9607109
[TBL] [Abstract][Full Text] [Related]
9. New high-technology products for the treatment of haemophilia.
Pipe SW; Saint-Remy JM; Walsh CE
Haemophilia; 2004 Oct; 10 Suppl 4():55-63. PubMed ID: 15479373
[TBL] [Abstract][Full Text] [Related]
10. Visions in haemophilia care.
Pipe S
Thromb Res; 2009 Dec; 124 Suppl 2():S2-5. PubMed ID: 20109652
[TBL] [Abstract][Full Text] [Related]
11. The history of haemophilia - a short review.
Schramm W
Thromb Res; 2014 Nov; 134 Suppl 1():S4-9. PubMed ID: 24513149
[TBL] [Abstract][Full Text] [Related]
12. Challenges for new haemophilia products from a manufacturer's perspective.
Schulte S
Thromb Res; 2014 Nov; 134 Suppl 1():S72-6. PubMed ID: 24360931
[TBL] [Abstract][Full Text] [Related]
13. Management of hemophilias--gene therapy to come?
Vajó Z; Sréter L
Acta Physiol Hung; 1996; 84(2):191-8. PubMed ID: 9046365
[TBL] [Abstract][Full Text] [Related]
14. Acquired haemophilia: dynamic whole blood coagulation utilized to guide haemostatic therapy.
Johansen RF; Sørensen B; Ingerslev J
Haemophilia; 2006 Mar; 12(2):190-7. PubMed ID: 16476097
[TBL] [Abstract][Full Text] [Related]
15. Advances in care of children with hemophilia.
Manco-Johnson MJ; Riske B; Kasper CK
Semin Thromb Hemost; 2003 Dec; 29(6):585-94. PubMed ID: 14719175
[TBL] [Abstract][Full Text] [Related]
16. Preclinical and clinical gene therapy for haemophilia.
Chuah MK; Collen D; Vandendriessche T
Haemophilia; 2004 Oct; 10 Suppl 4():119-25. PubMed ID: 15479384
[TBL] [Abstract][Full Text] [Related]
17. Prophylaxis in haemophilia patients with inhibitors.
Leissinger CA
Haemophilia; 2006 Dec; 12 Suppl 6():67-72; discussion 72-3. PubMed ID: 17123397
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy for haemophilia "A" and "B": efficacy, safety and immune consequences.
Chuah MK; Vandendriessche T
Bull Mem Acad R Med Belg; 2007; 162(5-6):357-61. PubMed ID: 18405006
[TBL] [Abstract][Full Text] [Related]
19. The hemophilias: progress and problems.
Mannucci PM; Tuddenbam EG
Semin Hematol; 1999 Oct; 36(4 Suppl 7):104-17. PubMed ID: 10595759
[TBL] [Abstract][Full Text] [Related]
20. The treatment of hemophilia A: from protein replacement to AAV-mediated gene therapy.
Youjin S; Jun Y
Biotechnol Lett; 2009 Mar; 31(3):321-8. PubMed ID: 18979215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
